Is Eyenovia Inc (NASDAQ: EYEN) a Risk-Worthy Bet for Bold Investors?

In the latest trading session, 3.92 million Eyenovia Inc (NASDAQ:EYEN) shares changed hands as the company’s beta touched 1.44. With the company’s most recent per share price at $0.09 changed hands at -$0.01 or -6.16% at last look, the market valuation stands at $9.45M. EYEN’s current price is a discount, trading about -2755.56% off its 52-week high of $2.57. The share price had its 52-week low at $0.08, which suggests the last value was 11.11% up since then. When we look at Eyenovia Inc’s average trading volume, we note the 10-day average is 25.41 million shares, with the 3-month average coming to 4.88 million.

Eyenovia Inc (NASDAQ:EYEN) trade information

Instantly EYEN was in red as seen in intraday trades today. With action -13.66%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -95.53%, with the 5-day performance at -13.66% in the red. However, in the 30-day time frame, Eyenovia Inc (NASDAQ:EYEN) is -81.06% down. Looking at the short shares, we see there were 2.14 million shares sold at short interest cover period of 2.45 days.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Eyenovia Inc (EYEN) estimates and forecasts

Data shows that the Eyenovia Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -87.78% over the past 6 months, a 10.61% in annual growth rate that is considerably lower than the industry average of 17.70%. Year-over-year growth is forecast to reach 22,441.69% up from the last financial year.

Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of 834.67k. 2 analysts are of the opinion that Eyenovia Inc’s revenue for the current quarter will be 700k. The company’s revenue for the corresponding quarters a year ago was 2.59k and 4.99k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 32,126.64%. The estimates for the next quarter sales put growth at 13,928.06%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 18.26%. The 2024 estimates are for Eyenovia Inc earnings to increase by 12.40%.

EYEN Dividends

Eyenovia Inc is expected to release its next quarterly earnings report in January.

Eyenovia Inc (NASDAQ:EYEN)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 9.99% of Eyenovia Inc shares while 13.73% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 15.25%. There are 13.73% institutions holding the Eyenovia Inc stock share, with ARMISTICE CAPITAL, LLC the top institutional holder. As of 2024-06-30, the company held 13.0037% of the shares, roughly 6.06 million EYEN shares worth $3.6 million.

VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 4.0365% or 1.88 million shares worth $1.12 million as of 2024-06-30.

Among Mutual Funds, the top two as of Jun 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 1.43 shares estimated at $0.13 million under it, the former controlled 1.65% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.50% of the shares, roughly 430.39 shares worth around $39595.0.